绿竹生物-B（02480）于2026年4月2日发布截至2026年3月31日的股份变动月报表。报告显示，公司本月并无新增发行、回购、注销或库存股份方面的变动，股本整体保持稳定。
截至3月末，公司普通股股本总数为202,449,032股（面值每股人民币1元），其中已发行股份198,913,232股，库存股份3,535,800股，与上月底持平。公司确认符合香港联合交易所有限公司相关规定的公众持股量要求。
根据公告，报告期内并无股份期权、认股权证、可换股票据或其他涉及发行新股的安排。公司同时确认严格遵守香港联交所《上市规则》及适用法律法规，相关证券发行及库存股份交易均获得董事会正式授权并履行相应程序。
该公告由联席公司秘书刘斯宇签署。公司表示，将继续按规定及时披露股份变动及相关信息。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.